Evaluation of Post Operative Pain and Success Rate After Pulpotomy

June 14, 2021 updated by: Shehab El Din Mohamed Saber, Ain Shams University

Comparative Evaluation of Post Operative Pain and Success Rate After Pulpotomy Using Different Tricalcium Silicate Based Materials (A Randomized Clinical Trial )

The aim of this randomized controlled trial is to assess the post-operative pain as primary outcome and the success rate as secondary outcome after pulpotomy using different calcium silicate based materials in mature permanent teeth diagnosed with irreversible pulpitis.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Setting and location :

Out-patients clinic of Endodontic Department, Faculty of Dentistry, Ain Shams University

Patient allocation:

Using computer generated randomization (www.randome.org), the participants will allocated randomly into three groups .

The sequentially numbers that will be generated, will be placed in opaque envelope until the intervention and each participant will be asked to select an envelope that determine which group of intervention he will be assigned.

Patient Classification:

Patients will be randomly divided into three groups according to material used in pulpotomy Group (1) Biodentine (n=20) Group (2) theracal PT (n=20) Group (3) Neoputty (n=20)

Procedural steps:

  • Pain scale chart will be given to each patient to rate his /her pain level before endodontic treatment as preoperative reading on a visual analogue scale (VAS)
  • Tooth will be anaesthetized using Local anesthesia containing Articaine with epinephrine 1:100,000.
  • Rubber dam isolation of tooth
  • Tooth surface disinfection using guaze soaked in 5.25% sodium hypochlorite
  • Access cavity will be performed using a carbide steel round bur and tapered diamond stone until complete deroofing.
  • Using a sterile excavator, the coronal pulp tissue will be excavated14
  • Cotton pellets soaked in 2.5 % sodium hypochlorite will be used to achieve hemostasis for 2-3 minutes
  • Once hemostasis will be achieved one of the three materials will be placed according to the manufacturer's instructions
  • Final restoration will be placed

Methods of evaluation

  1. Post operative pain
  2. Pulpotomy success rate

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Ain Shams University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients age between 20 and 40 years old.

    • Teeth diagnosed with symptomatic irreversible pulpitis.
    • Normal periapical condition confirmed by normal periapical radiograph or that with minimal widening of the PDL space.
    • The teeth are restorable.
    • Teeth probing depth and mobility should be within normal limits.

Exclusion Criteria:

  • Teeth with immature roots

    • Non restorable teeth
    • Bleeding could not be controlled after pulpotomy in 10 minutes.
    • Medically compromised patients with systemic complication that would alter the treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: biodentine
pulptomy with biodentine
pulpotomy
ACTIVE_COMPARATOR: Theracal PT
pulpotomy with Theracal PT
pulpotomy
ACTIVE_COMPARATOR: Neo Putty
pulpotomy with Neo putty
pulpotomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post operative pain
Time Frame: pre-operative
Each patient will be asked to fill the visual analogue scale to rate the pain level
pre-operative
post operative pain
Time Frame: 6 hours following the end of the procedure.
Each patient will be asked to fill the visual analogue scale to rate the pain level
6 hours following the end of the procedure.
post operative pain
Time Frame: 12 hours following the end of the procedure.
Each patient will be asked to fill the visual analogue scale to rate the pain level
12 hours following the end of the procedure.
post operative pain
Time Frame: 24 hours following the end of the procedure.
Each patient will be asked to fill the visual analogue scale to rate the pain level
24 hours following the end of the procedure.
post operative pain
Time Frame: 48 hours following the end of the procedure.
Each patient will be asked to fill the visual analogue scale to rate the pain level
48 hours following the end of the procedure.
post operative pain
Time Frame: 72 hours following the end of the procedure.
Each patient will be asked to fill the visual analogue scale to rate the pain level
72 hours following the end of the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulpotomy success
Time Frame: 3 months after the intervention
clinical and radiographic absence of inflammation
3 months after the intervention
Pulpotomy success
Time Frame: 6 months after the intervention
clinical and radiographic absence of inflammation
6 months after the intervention
Pulpotomy success
Time Frame: 9 months after the intervention
clinical and radiographic absence of inflammation
9 months after the intervention
Pulpotomy success
Time Frame: 12 months after the intervention
clinical and radiographic absence of inflammation
12 months after the intervention
Pulpotomy success
Time Frame: 18 months after the intervention
clinical and radiographic absence of inflammation
18 months after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ahmed Abdel Rahman Hashem, phd, Ain Shams University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2021

Primary Completion (ANTICIPATED)

June 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

June 7, 2021

First Submitted That Met QC Criteria

June 14, 2021

First Posted (ACTUAL)

June 22, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 22, 2021

Last Update Submitted That Met QC Criteria

June 14, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Root Canal Infection

Clinical Trials on vital pulp therapy

Subscribe